Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma
Clinical trial NCT03030261 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03030261
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-22
- Primary completion
- 2022-09-29
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.